Dumont, M.* ; Weber-Lassalle, N.* ; Joly-Beauparlant, C.* ; Ernst, C.* ; Droit, A.* ; Feng, B.* ; Dubois, S.* ; Collin-Deschesnes, A.* ; Soucy, P.* ; Vallee, M.* ; Fournier, F.* ; Lemacon, A.* ; Adank, M.A.* ; Allen, J.* ; Altmueller, J.* ; Arnold, N.* ; Ausems, M.G.E.M.* ; Berutti, R.* ; Bolla, M.K.* ; Bull, S.* ; Carvalho, S.* ; Cornelissen, S.* ; Dufault, M.R.* ; Dunning, A.M.* ; Engel, C.* ; Gehrig, A.* ; Geurts-Giele, W.R.R.* ; Gieger, C. ; Green, J.* ; Hackmann, K.* ; Helmy, M.* ; Hentschel, J.* ; Hogervorst, F.B.L.* ; Hollestelle, A.* ; Hooning, M.J.* ; Horvath, J.* ; Ikram, M.A.A.* ; Kaulfuss, S.* ; Keeman, R.* ; Kuang, D.* ; Luccarini, C.* ; Maier, W.* ; Martens, J.W.M.* ; Niederacher, D.* ; Nürnberg, P.* ; Ott, C.* ; Peters, A. ; Pharoah, P.D.P.* ; Ramirez, A.* ; Ramser, J.* ; Riedel-Heller, S.* ; Schmidt, G.* ; Shah, M.* ; Scherer, M.* ; Stäbler, A.* ; Strom, T.M.* ; Sutter, C.* ; Thiele, H.* ; van Asperen, C.J.* ; van der Kolk, L.* ; van der Luijt, R.B.* ; Volk, A.E.* ; Wagner, M.* ; Waisfisz, Q.* ; Wang, Q.* ; Wang-Gohrke, S.* ; Weber, B.H.F.* ; Devilee, P.* ; Tavtigian, S.* ; Bader, G.D.* ; Meindl, A.* ; Goldgar, D.E.* ; Andrulis, I.L.* ; Schmutzler, R.K.* ; Easton, D.F.* ; Schmidt, M.K.* ; Hahnen, E.* ; Simard, J.*
Uncovering the contribution of moderate-penetrance susceptibility genes to breast cancer by whole-exome sequencing and targeted enrichment sequencing of candidate genes in women of European ancestry.
Cancers 14:3363 (2022)
Rare variants in at least 10 genes, including BRCA1, BRCA2, PALB2, ATM, and CHEK2, are associated with increased risk of breast cancer; however, these variants, in combination with common variants identified through genome-wide association studies, explain only a fraction of the familial aggregation of the disease. To identify further susceptibility genes, we performed a two-stage whole-exome sequencing study. In the discovery stage, samples from 1528 breast cancer cases enriched for breast cancer susceptibility and 3733 geographically matched unaffected controls were sequenced. Using five different filtering and gene prioritization strategies, 198 genes were selected for further validation. These genes, and a panel of 32 known or suspected breast cancer susceptibility genes, were assessed in a validation set of 6211 cases and 6019 controls for their association with risk of breast cancer overall, and by estrogen receptor (ER) disease subtypes, using gene burden tests applied to loss-of-function and rare missense variants. Twenty genes showed nominal evidence of association (p-value < 0.05) with either overall or subtype-specific breast cancer. Our study had the statistical power to detect susceptibility genes with effect sizes similar to ATM, CHEK2, and PALB2, however, it was underpowered to identify genes in which susceptibility variants are rarer or confer smaller effect sizes. Larger sample sizes would be required in order to identify such genes.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publication type
Article: Journal article
Document type
Scientific Article
Thesis type
Editors
Keywords
Breast Cancer ; Genetic Susceptibility ; Whole-exome Sequencing ; Moderate-penetrance Genes
Keywords plus
Language
english
Publication Year
2022
Prepublished in Year
HGF-reported in Year
2022
ISSN (print) / ISBN
2072-6694
e-ISSN
ISBN
Book Volume Title
Conference Title
Conference Date
Conference Location
Proceedings Title
Quellenangaben
Volume: 14,
Issue: 14,
Pages: ,
Article Number: 3363
Supplement: ,
Series
Publisher
MDPI
Publishing Place
Day of Oral Examination
0000-00-00
Advisor
Referee
Examiner
Topic
University
University place
Faculty
Publication date
0000-00-00
Application date
0000-00-00
Patent owner
Further owners
Application country
Patent priority
Reviewing status
Peer reviewed
Institute(s)
Institute of Epidemiology (EPI)
POF-Topic(s)
30202 - Environmental Health
Research field(s)
Genetics and Epidemiology
PSP Element(s)
G-504091-004
G-504000-010
Grants
U.S. National Institutes of Health, National Center for Research Resources
Ministère de l'Économie, de la Science et de l'Innovation du Québec
the Government of Canada through Genome Canada and the Canadian Institutes of Health Re-search (GPH-129344), the Ministère de l'Économie, de la Science et de l'Innovation du Québec through Genome Quebec, and the Quebec Breast Cancer Foundation
Copyright
Erfassungsdatum
2022-09-01